These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2537340)

  • 1. The effects of intravenous clomipramine on neurohormones in normal subjects.
    Golden RN; Hsiao J; Lane E; Hicks R; Rogers S; Potter WZ
    J Clin Endocrinol Metab; 1989 Mar; 68(3):632-7. PubMed ID: 2537340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects.
    Schüle C; Baghai T; Laakmann G
    Neuroendocrinology; 2004 Jan; 79(1):54-62. PubMed ID: 14755134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity of the corticotropic axis to the serotoninergic agent clomipramine in obese women.
    Laferrère B; Lahlou N; Saltiel H; Roger M; Basdevant A; Oppert JM; Guy-Grand B
    Obes Res; 1994 Jul; 2(4):328-36. PubMed ID: 16353581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder.
    Mathew SJ; Coplan JD; Perko KA; Goetz RR; de la Neuz M; Hollander E; Liebowitz MR; Fallon BA
    Depress Anxiety; 2001; 14(4):199-208. PubMed ID: 11754126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men.
    Copinschi G; Van Onderbergen A; L'Hermite-Balériaux M; Szyper M; Caufriez A; Bosson D; L'Hermite M; Robyn C; Turek FW; Van Cauter E
    Sleep; 1990 Jun; 13(3):232-44. PubMed ID: 2356395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)].
    Schlienger JL; Kapfer MT; Singer L; Stephan F
    Acta Psychiatr Belg; 1980; 80(5):584-99. PubMed ID: 6786002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects.
    Golden RN; Ekstrom D; Brown TM; Ruegg R; Evans DL; Haggerty JJ; Garbutt JC; Pedersen CA; Mason GA; Browne J
    Am J Psychiatry; 1992 Sep; 149(9):1168-75. PubMed ID: 1323933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative neurotransmitter reuptake and anticholinergic potencies of the 8-hydroxy metabolites of clomipramine.
    Núñez R; Perel JM
    Psychopharmacol Bull; 1995; 31(2):217-21. PubMed ID: 7491371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glucocorticoids on pituitary hormonal responses to hypoglycemia. Inhibition of prolactin release.
    Copinschi G; L'Hermite M; Leclercq R; Golstein J; Vanhaelst L; Virasoro E; Robyn C
    J Clin Endocrinol Metab; 1975 Mar; 40(3):442-9. PubMed ID: 163844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study.
    Massoud AF; Hindmarsh PC; Brook CG
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4338-41. PubMed ID: 8954038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulatory effects of gamma-aminohydroxybutyric acid (GABOB) on growth hormone, prolactin and cortisol release in man.
    Takahara J; Yunoki S; Yakushiji W; Yamauchi J; Hosogi H; Ofuji T
    Horm Metab Res; 1980 Jan; 12(1):31-4. PubMed ID: 6244218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of naloxone on psychotropic drug-induced prolactin, growth hormone and cortisol secretion--a preliminary report.
    Huws D; Groom GV
    Postgrad Med J; 1980; 56 Suppl 1():70-4. PubMed ID: 7393831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine?
    Spreux-Varoquaux O; Gailledreau J; Vanier B; Bothua D; Plas J; Chevalier JF; Advenier C; Pays M; Brion S
    Biol Psychiatry; 1996 Sep; 40(6):465-73. PubMed ID: 8879466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man.
    Wiedemann E; Schwartz E; Frantz AG
    J Clin Endocrinol Metab; 1976 May; 42(5):942-52. PubMed ID: 178687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion.
    Schürmeyer TH; Avgerinos PC; Gold PW; Gallucci WT; Tomai TP; Cutler GB; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1103-8. PubMed ID: 6092407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of desipramine and clomipramine on pituitary-adrenal axis in man.
    Holl WR; Fehm HL; Voigt KH; Steiner K; Teller W
    Horm Metab Res; 1986 Feb; 18(2):134-7. PubMed ID: 3009292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
    Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
    J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity.
    Lykouras L; Markianos M; Hatzimanolis Y
    Neuropsychobiology; 2011; 63(2):77-81. PubMed ID: 21178381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent growth hormone, prolactin and cortisol stimulation after i.v. administration of desimipramine in human subjects.
    Laakmann G; Schoen HW; Blaschke D; Wittmann M
    Psychoneuroendocrinology; 1985; 10(1):83-93. PubMed ID: 4001280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.